Student Research Association for Clinical Nutrition, Department of General Surgery and Clinical Nutrition, Centre of Postgraduate Medical Education, Medical University of Warsaw, 00-401 Warsaw, Poland.
Department of Education and Research in Health Sciences, Faculty of Health Sciences, Medical Univeristy of Warsaw, 00-518 Warsaw, Poland.
Nutrients. 2024 May 22;16(11):1569. doi: 10.3390/nu16111569.
Palliative care patients with malignant bowel obstruction are particularly at risk of developing malnutrition, which in turn directly shortens survival time and worsens quality of life (QoL). According to the available data, the survival time in this patient group is often less than three months. To avoid further complications related to malnutrition and poor outcomes in oncological therapy, nutritional therapy such as home parenteral nutrition (HPN) is offered. The aim of this study was to investigate whether nutritional status is a prognostic factor for survival in palliative care patients with malignant inoperable bowel obstruction qualified for home parenteral nutrition and which nutritional assessment tool has the most accurate prognostic value. This retrospective observational analysis included 200 patients with malignant bowel obstruction referred for home parenteral nutrition between January 2018 and August 2023. The analysis included laboratory test results, body mass index (BMI), Subjective Global Assessment (SGA), Nutritional Risk Index (NRI), Geriatric Nutritional Risk Index (GNRI), Prognostic Nutritional Index (PNI) and malnutrition as defined by the Global Leadership Initiative on Malnutrition (GLIM). The average survival time of the patients was 75 days. Patients with higher NRI and PNI scores were more likely to survive (NRI: < 0.001; PNI: < 0.001). The GLIM criteria, SGA scores and BMI values did not prove to be good prognostic factors for survival (GLIM = 0.922, SGA = 0.083, BMI = 0.092). The results suggest that the use of NRI and PNI may be helpful in prognosing survival in these patients and that prevention of the development of malnutrition through earlier nutritional assessment and intervention should be considered in this patient group.
姑息治疗中伴有恶性肠梗阻的患者尤其有发生营养不良的风险,而营养不良反过来又直接缩短了生存时间并降低了生活质量(QoL)。根据现有数据,该患者群体的生存时间通常不到三个月。为避免与营养不良相关的进一步并发症以及肿瘤治疗结果不佳,会提供营养治疗,例如家庭肠外营养(HPN)。本研究旨在探讨在姑息治疗中伴有恶性、不可切除性肠梗阻且适合家庭肠外营养的患者中,营养状况是否为生存的预后因素,以及哪种营养评估工具具有最准确的预后价值。这项回顾性观察性分析纳入了 200 名于 2018 年 1 月至 2023 年 8 月期间因恶性肠梗阻接受家庭肠外营养的患者。分析包括实验室检查结果、体重指数(BMI)、主观全面评估(SGA)、营养风险指数(NRI)、老年营养风险指数(GNRI)、预后营养指数(PNI)和全球营养不良倡议(GLIM)定义的营养不良。患者的平均生存时间为 75 天。NRI 和 PNI 评分较高的患者更有可能存活(NRI:<0.001;PNI:<0.001)。GLIM 标准、SGA 评分和 BMI 值并未证明是生存的良好预后因素(GLIM:=0.922,SGA:=0.083,BMI:=0.092)。结果表明,NRI 和 PNI 的使用可能有助于预测这些患者的生存情况,并且应该考虑在该患者群体中通过早期营养评估和干预来预防营养不良的发生。